Longitudinal Study of Health Literacy in the Municipality of Leiria
ConditionHealth Literacy
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorInstituto Politécnico de Leiria
About this trial
Health literacy (HL) is a topic of increasing importance todays' ever-changing world. Over the past few decades, HL has gained importance, as it is a factor related to health behaviors and outcomes. In Portugal, the last survey was in 2016 and 61% of the population had a problematic or inadequate level of HL in general. Lisa is a cohort study that will measure HL in the adult population residing in the municipality of Leiria over the next 4 years, with measurements every 2 years. Over the years we will promote activities and interventions adjusted to the needs of Leiria's population. At the end we want to understand the changes during the years and improve the health care provided.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
The study population will be composed by adults (≥ 18 years old) who are non-institutionalized and living in private households in Leiria.
Disqualifiers
Residing in hospitals, asylums, military barracks or prisons. Individuals who are unable to speak Portuguese or who reveal an inability to respond to the questionnaire, either directly or through a person who lives with them.
Trial population
The study population will be composed by adults (≥ 18 years old) who are non-institutionalized and living in private households in Leiria. Because there is no reliable list of households in Portugal, a random selection of points in the map of each location will be performed. Addresses will be selected, and afterwards the "random-walks" will start. Interviewers will register each selected address and, if someone is at home, they will collect information on age and gender of the different people living in that address and will give information about the study. In order to assure the successful data collection, up to three visits to each address (one during the weekend) will be made. At each address, the person whose birthday is closest to the day of the visit (aged 18 years or older) will be selected for the interview and, if available, will be immediately asked to answer the questionnaire.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
4,003 Participants
are grouped into 1 trial groupGroup A: Residents of the municipality of Leiria aged 18 years or more.
Trial outcomes
Primary outcomes
1
Health literacy
HL will be measured by European Health Literacy Survey Questionnaire (HLS-EU-Q16). HLS-EU-Q16 was developed to measure HL in populations, based on a conceptual framework. Each item in the questionnaire assesses the perceived difficulty of a specific health-related task for the respondent. The HLS-EU-Q16 was translated and validated for Portuguese population. The scale contains 16 items that measure HL. Each item assesses the perceived difficulty of completing a specific health-related task by asking "On a scale from very difficult to very easy, how easy would you say it is to \[e.g, find information on symptoms of illnesses that concern you\]?" Each item is rated on a 4-point Likert-type scale (1, very difficult; 2, fairly difficult; 3, fairly easy; 4, very easy). A higher difficulty score is assumed with lower HL.
Time frame
Health literacy: measuring change over the next 10 yearsSecondary outcomes
1
Anxiety and depression
To evaluate symptoms of anxiety and depression we applied the Hospital Anxiety and Depression Scale (HADS) Portuguese validated version. The HADS is a screening tool to apprehend clinically significant states of anxiety and depression in a non-psychiatric hospital setting. Individual anxiety and depression scores are calculated by summation of the appropriate seven items and thus can range from 0 to 21, with higher scores indicating higher levels of anxiety or depression, respectively. In both subscales, a score between 0 and 7 is "normal," between 8 and 10 "mild," between 11 and 14 "moderate," and between 15 and 21 "severe". Presence of anxiety and depression symptoms is defined when HADS scale is ≥11.
Time frame
Anxiety and depression: measuring change over the next 10 years2
Metabolic risk
Metabolic risk is assessed by the Finnish Diabetes Risk Score-FINDRISC (FINDRISC). FINDRISC is a simple and practical tool originally designed in Finland to identify individuals at high risk of type 2 diabetes mellitus onset, without the need for laboratory tests. The score is based on eight easily identifiable parameters (age, body mass index, waist circumference, hypertension, physical activity level, diet, occurrence of previous hyperglycemia, and family history of diabetes) and provides a measure of the probability of developing diabetes over the next 10 years. Findrisc score varies between 0 and 24. A risk score of 0-14 points indicates a low to moderate risk of diabetes (1-17% chance of diabetes over 10 years). A risk score of 15-20 points indicates a high risk of diabetes (33% chance of diabetes over 10 years). A risk score of \>20 points indicates a very high risk of diabetes (50% chance of diabetes over 10 years).
Time frame
Metabolic risk: measuring change over the next 10 yearsLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: